AEMD Kapitalisasi Akuntansi Aethlon Medical Inc

Aethlon Medical (AEMD) relies on local US contractors, which guarantees the uninterrupted shipment of filtration cartridges. Business growth is driven by government subsidies, success in oncology tests, and defense orders, with the indicator standing at 0.02. The visualization of market value on GURU.Markets confirms the company's immense potential as a creator of advanced blood purification systems for removing cancer cells and viruses.

Aethlon Medical specializes in developing proprietary physical blood pathogen filtration systems, which requires significant capital expenditures in intellectual property and equipment. The equity trend on the balance sheet reflects the difference between all assets and liabilities, demonstrating the real value of the company's net resources and its degree of financial resilience to external shocks.